Label: VARDENAFIL tablet, orally disintegrating

Patients with a "crowed" optic disc may also be at an increased risk of NAION. Sudden hearing loss - patients should stop treatment and seek medical attention in the event of sudden decrease or loss in hearing Alpha-blockers - caution is advised when PDE5 inhibitors are co-administered with alpha-blockers.

Advice Point	Explanation
Take on an empty stomach	Food, especially high-fat, may delay absorption
Do not combine with nitrates	Can cause severe hypotension
Avoid alcohol consumption	Can impair effectiveness and cause side effects
Follow prescribed dosage	To minimize side effects and interactions

In some patients, concomitant use of these two drug classes can lower blood pressure significantly leading to symptomatic hypotension (for example, fainting) QT prolongation - patients with congenital QT syndrome or taking class IA or III antiarrhythmics should avoid using Vardenafil Other erectile dysfunction therapies - the safety and efficacy of vardenafil used in combination with other treatments for ED have not been studied.

Region	Average Price (per tablet)	Availability	Notes
North America	$2 - $5	Widely available	Prescription required
Europe	€2 - €4	Available at pharmacies	Generic options common
Asia	$1 - $3	Readily available	Often lower cost
Africa	$2 - $4	Varies by country	May require import or special order

Signs and symptoms may include reversible back pain/myalgia and/or "abnormal vision." Standard supportive measures should be taken as required.

• Vardenafil 10 mg tablets treat erectile dysfunction in men.
• The medication works by increasing blood flow to the penis.
• Take vardenafil 10 mg about 30 minutes before activity.
• It can be taken with or without food, but high-fat meals may delay effects.
• Maximum recommended dose is one tablet per 24 hours.
• Vardenafil may cause side effects like headache or flushing.
• Do not use vardenafil if you take nitrates for chest pain.
• Consult a doctor before using vardenafil if you have heart problems.
• Store vardenafil tablets at room temperature, away from moisture.
• Alcohol can increase side effects of vardenafil.

Renal dialysis is not expected to accelerate clearance as vardenafil is highly bound to plasma proteins and not significantly eliminated in the urine.

What other drugs will affect vardenafil?

Are there ongoing research efforts for new formulations? Limited, primarily from generic manufacturers focusing on fast-dissolving forms or combination therapies; innovation is more incremental than breakthrough. Country-specific approval processes, patent laws, and price regulations influence how quickly new generic or branded formulations enter markets. Erectile Dysfunction Drugs Market by Product, Distribution Channel, and Region: Global Forecast to 2028. [5] U.S.

What are the serious side effects of vardenafil?

Food and Drug Administration (FDA). 10 mg as needed, 60 minutes prior to sexual activity Increase to 20 mg or decrease to 5 mg based on efficacy/tolerability For patients taking potent or moderate inhibitors of CYP3A4, dose adjustment is as follows: Ritonavir: no more than ceridaviescampaigner co uk 2.5 mg in a 72-hour period Indinavir, saquinavir, atazanavir, ketoconazole 400 mg daily, itraconazole 400 mg daily, clarithromycin: no more than 2.5 mg in a 24-hour period Ketoconazole 200 mg daily, itraconazole 200 mg daily, erythromycin: no more than 5 mg in a 24-hour period. Cardiovascular effects - patients should not use Vardenafil if sex is inadvisable due to cardiovascular status. Risk of priapism - in the event that an erection lasts more than 4 hours, the patient should seek immediate medical assistance Effects on the eye - patients should stop treatment and seek medical attention in the event of sudden loss of vision in one or both eyes, which could be sign of nonarteritic anterior ischemic optic neuropathy (NAION). Use with caution, and only when the anticipated benefits outweigh the risks, in patients with a history of NAION. Pregnancy: Pregnancy Category B; not indicated for use in women.

Patient Type	Recommended Dose	Notes
Adult Men with ED	10 mg	1 hour before activity
Elderly Patients	5-10 mg	Adjust based on tolerability
Patients with Liver Impairment	5 mg	Lower dose recommended
Use with CYP3A4 inhibitors	5 mg	To reduce adverse risk

Nursing Mothers: Not indicated for use in women. Renal Impairment: Do not use in patients on renal dialysis; no dosage adjustment necessary in patients with ClCr 30-80 mL/min.

Product	Dosage	Quantity + Bonus	Price
Super Kamagra	160 mg	8 Pills	69.23€ 65.93€	Buy
Cialis Professional	20mg	270 + 6 Pills	623.07€ 593.40€	Buy
Kamagra Soft Tabs	100 mg	272 + 12 Pills	593.42€ 565.16€	Buy
Levitra Generic	60mg	270 + 10 Pills	714.53€ 680.50€	Buy
Kamagra Polo	100 mg	32 Pills	125.88€ 119.89€	Buy
Kamagra Oral Jelly	100 mg	30 + 5 Sachets	136.20€ 129.71€	Buy
Kamagra Soft Tabs	100mg	272 + 12 Pills	593.42€ 565.16€	Buy
Kamagra	100mg	60 + 4 Pills	201.34€ 191.75€	Buy
Levitra Generic	10mg	120 + 10 Pills	178.59€ 170.09€	Buy
Kamagra Gold	50 mg	84 + 6 Pills	224.77€ 214.07€	Buy
Cialis Original	20mg	92 + 4 Pills	377.99€ 359.99€	Buy
Kamagra Oral Jelly	100mg	220 + 18 Sachets	662.24€ 630.70€	Buy
Cialis Original	20mg	34 + 2 Pills	183.99€ 175.23€	Buy
Viagra Oral Jelly	100mg	10 Sachets	46.36€ 44.15€	Buy
Kamagra Soft Tabs	100mg	120 + 6 Pills	311.78€ 296.93€	Buy

Hepatic Impairment: Do not use in patients with severe impairment (Child-Pugh C); dosage adjustment is necessary in patients with moderate impairment. Pediatric Patients: Not indicated for use in pediatric patients; safety and efficacy have not been established in this population.

Generic vs Brand

The segment including vardenafil accounts for roughly 20% of this market, with an estimated revenue of $800 million in 2022. Key manufacturers include Bayer, Teva Pharmaceuticals, and Sun Pharma. The generic segment's share increased from 15% in 2015 to over 50% by 2022, driven by patent expirations and regional generics proliferation. Bayer's patent for Levitra expired in 2018, allowing generic manufacturers to enter multiple markets. This reduced prices by an estimated 40–60%, impacting branded sales.

Related treatment guides

The expiration facilitated increased accessibility and expanded the patient base, especially in emerging markets. In the US, the final patent expiration occurred in 2020. The European patent expired in 2017, leading to a surge in generic imports. Patent cliffs across major markets significantly shifted revenue streams, transitioning from branded dominance to a generics-focused market. The drug's pharmacology remains stable with a half-life of 4–5 hours, allowing for flexible dosing.

Vardenafil Side Effects

It competes with tadalafil (Cialis) and sildenafil (Viagra), which have similar efficacy but differ in duration and side effect profile. Commercially, the ED market is expanding due to increasing prevalence related to aging populations and rising awareness. The global aging demographic is expected to increase ED prevalence from 10% to 30% in men aged 40–70. Market growth is driven by increased focus on sexual health, over-the-counter availability in some regions, and newer formulations improving patient adherence. The popularity of combination therapies and the rise of telemedicine further influence demand dynamics. Geriatric Patients: No differences in safety and effectiveness noted between elderly (≥65 years of age) and younger patients. However, due to increased vardenafil concentrations in the elderly, a starting dose of 5 mg should be considered in the elderly.

• Vardenafil 10 mg enhances natural erectile response.
• The medication is prescription-only in most countries.
• Common brand names include Levitra and Staxyn.
• Do not crush or split the tablet unless instructed.
• Using more than the prescribed dose can increase risk.
• Vardenafil is a phosphodiesterase inhibitor.
• It is not intended for use by women.
• Possible side effects include nasal congestion and dizziness.
• Seek medical advice if you experience priapism.
• Keep out of reach of children.

Vardenafil may add to the blood pressure lowering effects of antihypertensive agents.

Further information

Projection estimates forecast the ED market reaching over $6.5 billion globally by 2028, with vardenafil contributing approximately 15–20% of this value. Compound annual growth rate (CAGR) calculations suggest a 5–6% growth from 2023 to 2028, primarily propelled by: Expansion into emerging markets (Asia-Pacific, Latin America) Increased acceptance of generics, reducing patient costs Rise in over-the-counter product availability Technological innovations in formulation (e.g., fast-dissolving tablets) Regional variations could influence market share: North America is expected to be the dominant segment, but Asia-Pacific will witness the fastest growth, with a CAGR near 8%, due to higher prevalence and lower treatment access costs. Manufacturing costs for vardenafil have declined due to economies of scale and global production. Generic production costs are estimated at $0.10–$0.15 per pill, compared to branded formulations at $1.00–$2.00, creating profit margins of 85–90% for generics. Regulatory harmonization reduces approval timelines and cost, fostering quicker market entry.

More common

Countries with streamlined approval processes, such as India and Brasil, enable faster revenue realization. Conversely, stringent regulations in the US and EU can delay launches, impacting short-term revenue but fostering long-term stability. Pricing policies vary, with government-mandated price caps in several markets influencing profit margins. For instance, India enforces prices 30–40% lower than international reference prices, reducing profit potential libido for women but increasing volume sales. Generic vardenafil dominates due to patent expiry, with leading players capturing over 60% of the accessible market: Teva Pharmaceuticals: Largest global producer with extensive distribution channels.

Dosage Forms & Strengths

Sun Pharma: Focused on Asian markets, rapidly expanding in Latin America. Mylan: Active in the US and Europe with competitive pricing. Brand dominance persists in some regions, especially where patent protections remain valid or where consumer preference favors branded formulations. Innovation in delivery mechanisms (e.g., fast-dissolving tabs, new formulations) is limited but ongoing, primarily driven by generic manufacturers. Patent litigation or patent extensions delaying generic entry. Effects on Blood Pressure and Heart Rate when Combined with Nitrates: A study was conducted in which the blood pressure and heart rate response to 0.4 mg nitroglycerin (NTG) sublingually was evaluated in 18 healthy subjects following pretreatment with vardenafil 20 mg at various times before NTG administration. Additional blood pressure and heart rate changes were not detected when vardenafil 20 mg was dosed 24 hours before NTG.

• Vardenafil 10 mg is one of several ED treatment options.
• It is generally well-tolerated when used properly.
• Take care to follow your healthcare provider’s instructions.
• Possible interactions with antihypertensive drugs exist.
• Do not drive or operate machinery if feeling dizzy.
• Keep a record of any side effects experienced.
• The medication is not a cure for erectile dysfunction.
• Combining vardenafil with other ED drugs is dangerous.
• Take the tablet with a full glass of water.
• Consult your doctor for dose adjustments if needed.

Because the disease state of patients requiring nitrate therapy is anticipated to increase the likelihood of hypotension, the use of vardenafil by patients on nitrate therapy or on nitric oxide donors is contraindicated.

5.12 Phenylketonurics

Competition from new drugs or alternative therapies. Regulatory changes increasing approval or manufacturing costs. Pricing pressures due to government-mandated price reductions. Operational risk stems from supply chain disruptions and geopolitical issues impacting manufacturing or distribution. Patent expirations significantly increased generic entry, reducing prices and expanding access.

From Rybelsus to the Ozempic Pill: What Pharmacists Need to Know About the Next Generation of Oral Semaglutide

Revenue growth predictions remain positive but are moderated by regulatory policies and pricing pressures. Emerging markets will drive growth, with regional variations influencing market share. Innovation in formulation remains limited but could alter competitive dynamics. Overall, the market for vardenafil hydrochloride continues to evolve with rising demand for ED treatments and increased generic availability. How does vardenafil compare to other PDE5 inhibitors?

Who should not take vardenafil?

Vardenafil has a similar efficacy profile to sildenafil and tadalafil but features a quicker onset of action. Its half-life of 4–5 hours suits flexible dosing. Pricing is affected by patent status, regional regulation, competition, and whether the drug is branded or generic. Which markets offer the highest growth potential? Emerging markets such as India, China, and Latin America present the highest growth potential due to increasing prevalence and affordability factors. Blood Pressure Effects in Patients on Stable Alpha-Blocker Treatment: Three clinical pharmacology studies were conducted in patients with benign prostatic hyperplasia (BPH) on stable-dose alpha-blocker treatment, consisting of alfuzosin, tamsulosin or terazosin. The design was a randomized, double blind, cross-over study with four treatments: vardenafil 5 mg or placebo administered simultaneously with the alpha-blocker and vardenafil 5 mg or placebo administered 6 hours after the alpha- blocker.

• Side effects can include headache, flushing, or stomach upset.
• Serious side effects are rare but require immediate medical attention.
• Vardenafil may cause changes in color vision.
• Use caution if using other medication for blood pressure.
• The medication helps improve erectile function temporarily.
• Do not share tablets with others.
• Follow storage instructions to maintain efficacy.
• Report any allergic reactions promptly.
• The drug should be used only under medical supervision.
• Used responsibly, vardenafil can improve quality of life.

Study 2: This study was designed to evaluate the effect of 10 mg vardenafil (stage 1) and 20 mg vardenafil (stage 2) compared to placebo, when administered to a single cohort of BPH patients (n=23) on stable therapy with tamsulosin 0.4 mg or 0.8 mg daily for at least four weeks.

Owner

Fabienne Heyne
[email protected]

Design & Implementation

Jonas Bünter
www.jonas.work

Photography

Angelika Annen
www.angelikaannen.ch